Evidence map›Paper›PMID 23766644›Full record

Trial reportInternational journal of chronic obstructive pulmonary disease2013

Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease.

Jan Willem H Kocks, Jan Willem K van den Berg, Huib A M Kerstjens, Steven M Uil, Judith M Vonk, Ynze P de Jong, Ioanna G Tsiligianni, Thys van der Molen

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of chronic obstructive pulmonary disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Article
  3. Observational
  4. Article
  5. Functional respiratory imaging: heterogeneity of acute exacerbations of COPD.International journal of chronic obstructive pulmonary disease · 2018
    Article
  6. Review
  7. Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care.International journal of chronic obstructive pulmonary disease · 2017
    Article
  8. Observational
  9. A real-world evaluation of indacaterol and other bronchodilators in COPD: the INFLOW study.International journal of chronic obstructive pulmonary disease · 2015
    Observational
  10. Do females behave differently in COPD exacerbation?International journal of chronic obstructive pulmonary disease · 2015
    Article
  11. Observational
  12. Article
  13. COPD management: role of symptom assessment in routine clinical practice.International journal of chronic obstructive pulmonary disease · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jan Willem H KocksDepartment of General Practice, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Jan Willem K van den Berg
Huib A M Kerstjens
Steven M Uil
Judith M Vonk
Ynze P de Jong
Ioanna G Tsiligianni
Thys van der Molen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExacerbations of chronic obstructive pulmonary disease (COPD) are a major burden to patients and to society. Little is known about the possible role of day-to-day patient-reported outcomes during an exacerbation. This study aims to describe the day-to-day course of patient-reported health status during exacerbations of COPD and to assess its value in predicting clinical outcomes.

methodsData from two randomized controlled COPD exacerbation trials (n = 210 and n = 45 patients) were used to describe both the feasibility of daily collection of and the day-to-day course of patient-reported outcomes during outpatient treatment or admission to hospital. In addition to clinical parameters, the BORG dyspnea score, the Clinical COPD Questionnaire (CCQ), and the St George's Respiratory Questionnaire were used in Cox regression models to predict treatment failure, time to next exacerbation, and mortality in the hospital study.

resultsAll patient-reported outcomes showed a distinct pattern of improvement. In the multivariate models, absence of improvement in CCQ symptom score and impaired lung function were independent predictors of treatment failure. Health status and gender predicted time to next exacerbation. Five-year mortality was predicted by age, forced expiratory flow in one second % predicted, smoking status, and CCQ score. In outpatient management of exacerbations, health status was found to be less impaired than in hospitalized patients, while the rate and pattern of recovery was remarkably similar.

conclusionDaily health status measurements were found to predict treatment failure, which could help decision-making for patients hospitalized due to an exacerbation of COPD.

Indexed as

Pulmonary Disease, Chronic ObstructiveAdrenal Cortex HormonesAgedDisease ProgressionDyspneaFemaleHealth Status DisparitiesHospitalizationHumansMaleMaximal Expiratory Flow RateMiddle AgedNetherlandsOutcome Assessment, Health CarePatient ParticipationPrognosisAdrenal Cortex HormonesadmissionClinical COPD Questionnairehealth statushospitalprediction

Identifiers

PMID23766644
PMCPMC3678711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.